Avril Liu
About Avril Liu
Avril Liu is a Clinical Study Start Up Manager at BeiGene in Beijing, China, with extensive experience in clinical research and document review.
Company
Avril Liu currently works at BeiGene as a Clinical Study Start Up Manager. BeiGene focuses on developing molecularly targeted and immuno-oncology drug candidates for cancer treatment.
Title
Avril Liu holds the title of Clinical Study Start Up Manager. In this role, she oversees the initiation of clinical trials, ensuring compliance with regulatory standards and company protocols.
Work History at Covance
Avril Liu worked at Covance as a Document Reviewer from 2015 to 2018 in Beijing City, China. During her tenure, she specialized in reviewing essential clinical documents to ensure they met regulatory and quality standards.
Work History at Parexel
Prior to working at Covance, Avril Liu was employed at Parexel as a Clinical Research Associate from 2012 to 2015. Her responsibilities included monitoring clinical trials and ensuring the accuracy and integrity of data collected in Beijing City.
Projects and Initiatives
At BeiGene, Avril Liu led the setup of company-level working processes and acts as the only Document Reviewer in China, reporting to the APAC manager. She provides training to SSU and CRA teams, works cross-functionally with Regulatory Affairs, and serves as a consultant for drafting China country-level ICFs.
Clinical Expertise
Avril Liu has experience in quality review of investigational package documents such as protocol, ICF, and FDA1572. She has led global multi-center phase III and phase II clinical studies in therapeutic areas like Cardiovascular, Rheumatic, Oncology, Gastrointestinal, and Respiratory.